SAB Biotherapeutics - 53 Year Dividend History | SABS

Historical dividend payout and yield for SAB Biotherapeutics (SABS) since 1971. The current TTM dividend payout for SAB Biotherapeutics (SABS) as of May 24, 2024 is $0.00. The current dividend yield for SAB Biotherapeutics as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.002B
SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.
Stock Name Country Market Cap PE Ratio